Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pattern of Failure and Feasibility of Consolidative Stereotactic Radiotherapy in Third-generation EGFR-TKI-treated Metastatic EGFR-mutant Non-small Cell Lung Cancer: A Prospective, Observational Study

NCT06613633 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06613633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06613633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pattern of Failure and Feasibility of Consolidative Stereotactic Radiotherapy in Third-generation EGFR-TKI-treated Metastatic EGFR-mutant Non-small Cell Lung Cancer: A Prospective, Observational Study
Lead sponsor
Fudan University
Phase
Observational
Overall status
Completed
Start date
September 1, 2018
Completion date
February 20, 2026
Enrollment
4,000 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc (advanced non-small cell lung cancer), third-generation tki